4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000004
Chief Discovery Officer acquired 6,020 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kreitzer Anatol Chief Discovery Officer | 2026-02-05 | Grant or award | +6,020 | 259,928 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kreitzer Anatol Chief Discovery Officer | 2026-02-05 | Grant or award · Employee Stock Option (right to buy) | +24,455 | 24,455 | D: show line 2 in the form |
Loading xslF345X05/form4-02092026_050207.xml…